##  [Recent development on amendments of the Drug Administration Law (draft for consultation)](/en_GB/new/recent-development-amendments-drug-administration-law-draft-consultation) 

# Recent development on amendments of the Drug Administration Law (draft for consultation)





China - 01 / 30 / 2018





Corporate China Commentary 1-2018













- <a aria-label="Link" class="fs-5" data-content="Copied link" data-placement="top" data-toggle="popover" data-trigger="focus" data-url="https://www.garrigues.com/en_GB/new/recent-development-amendments-drug-administration-law-draft-consultation" id="get-app-artwork" role="button" tabindex="0"></a>
- [](https://www.linkedin.com/sharing/share-offsite/?url=https://www.garrigues.com/en_GB/new/recent-development-amendments-drug-administration-law-draft-consultation)
- [](<https://twitter.com/intent/tweet?text=Recent development on amendments of the Drug Administration Law (draft for consultation)&url=https://www.garrigues.com/en_GB/new/recent-development-amendments-drug-administration-law-draft-consultation>)
- [](<https://www.facebook.com/sharer.php?u=https://www.garrigues.com/en_GB/new/recent-development-amendments-drug-administration-law-draft-consultation&t=Recent development on amendments of the Drug Administration Law (draft for consultation)>)

[DOWNLOAD DOCUMENT

![Download](/sites/default/files/inline-images/flecha-abajo.png)](/sites/default/files/noticias/files/corporate-china-commentary-1-2018.pdf) 







   Previous    Next  















**To deepen the reform of drug evaluation and approval system, encourage innovations in drugs, and safeguard the rights and interests of the public in regard to drug consumption, China Food and Drug Administration (the “CFDA”) has published series of pharmaceutical laws and regulations recently. Among others, the most notable is the Drug Administration Law of the People’s Republic of China (draft for consultation) (the “Draft”) promulgated on October 23th, 2017 due to several major reforms in the area of drug registration and administration.**





According to the Draft, China will fully adopt a drug Market Authorization Holder (the “MAH”) system, the approval regime of clinical trials will be simplified, and overseas trial data will be accepted in drug registration, though an on-site check by CFDA might still be applied.

- 1\. IMPLEMENTING THE DRUG MARKETING AUTHORIZATION HOLDER SYSTEM
- 2\. CANCELLING CERTIFICATES OF GMP AND GSP
- 3\. SIMPLIFICATION OF THE ADMINISTRATIVE APPROVAL OF CLINICAL TRIALS
- 4\. DEFINITUDE AND CONCRETIZATION OF LEGAL LIABILITIES
- 5\. CONCLUSION











[China](/en_GB/tags/china), [Corporate](/en_GB/tags/corporate)







 

 



 

 

### Contacts

 

 ![](/sites/default/files/styles/medium/public/team/photo/Manuel_Torres_Salazar_20230511.jpg?itok=XIQSiRLy)

[Manuel Torres](/en_GB/team/manuel-torres-salazar)




![](/themes/custom/garriguestheme/img/iconos/email-contacto.svg)[Contact](<mailto:manuel.torres@garrigues.com >)

- +86 21 5228 1122
    
    [Shanghai](https://www.garrigues.com/en_GB/office/shanghai)
 










 ![Diego D’Alma - Garrigues](/sites/default/files/styles/medium/public/team/photo/Diego_DAlma_20230511.jpg?itok=zx9sXStr)

[Diego D'Alma](/en_GB/team/diego-dalma)




![](/themes/custom/garriguestheme/img/iconos/email-contacto.svg)[Contact](<mailto:diego.dalma@garrigues.com >)

- +34 95 207 55 25
    
    [Malaga](https://www.garrigues.com/en_GB/office/malaga)
- [Asia-Pacific Desk](https://www.garrigues.com/en_GB/office/asia-pacific-desk)
- [German Desk](https://www.garrigues.com/en_GB/office/german-desk)
 










 

[Find more professionals](../team)

 

 



 

### Related services 

 

- [Corporate and M&amp;A ](/en_GB/services/corporate-and-ma)
 


 

 



 

### Related offices

 

- - [Shanghai](/en_GB/office/shanghai)
 


 

 



 

## Find a publication

   

- [Administrative and Constitutional Law](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1422)
- [Agribusiness and Food](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1417)
- [Automotive](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1419)
- [Banking and Finance](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1443)
- [Corporate and M&amp;A](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1441)
- [Corporate Governance and Sustainable Development](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A12823)
- [Criminal Law and Internal Investigations](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1434)
- [Data Economy, Privacy and Cybersecurity](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10913)
- [Dispute Resolution: Litigation and Arbitration](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1412)
- [Energy](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10916)
- [EU and Antitrust Law](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1416)
- [Family Business](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1413)
- [Fashion Law](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1435)
- [Financial Regulation](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10915)
- [G-advisory](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A12821)
- [Human Capital Services](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1431)
- [Infrastructure](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10914)
- [Insurance](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1438)
- [Intellectual Property](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1421)
- [Labor and Employment](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1424)
- [Life Sciences and Healthcare](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1429)
- [Media and Entertainment](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1433)
- [Planning, Zoning and Environment](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1444)
- [Private Equity](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1439)
- [Real Estate](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10927)
- [Restructuring and Insolvency](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1420)
- [Securities Markets](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1442)
- [Sports](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1430)
- [Startups &amp; Open innovation](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1426)
- [Sustainability](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A10921)
- [Tax](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1425)
- [Technology, Communications and Digital](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1436)
- [Tourism and Hotels](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1432)
- [Transport, Logistics and Shipping](/en_GB/markdownify/node/6070?f%5B0%5D=service%3A1428)

 Facet Services detail

 



- [Publications](/en_GB/markdownify/node/6070?f%5B0%5D=publication_type%3A794)
- [Newsletters](/en_GB/markdownify/node/6070?f%5B0%5D=publication_type%3A107)
- [Garrigues collection](/en_GB/markdownify/node/6070?f%5B0%5D=publication_type%3A101)
- [Laws: amendments at a glance](/en_GB/markdownify/node/6070?f%5B0%5D=publication_type%3A104)
- [News](/en_GB/markdownify/node/6070?f%5B0%5D=publication_type%3A105)

 Facet Publication type detail

 



  Min  

 Max  

 







 

## News search engine